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Summary
Loci for autosomal dominant “zonular pulverulent” cat-
aract have been mapped to chromosomes 1q (CZP1) and
13q (CZP3). Here we report genetic refinement of the
CZP3 locus and identify underlying mutations in the
gene for gap-junction protein a-3 (GJA3), or connexin46
(Cx46). Linkage analysis gave a significantly positive
two-point LOD score (Z) at marker D13S175 (maxi-
mum Z ; maximum recombination fre-[Z ] 1 7.0max
quency ). Haplotyping indicated that CZP3[v ]  0max
probably lies in the genetic interval D13S1236–
D13S175–D13S1316–cen–13pter, close to GJA3. Se-
quencing of a genomic clone isolated from the CZP3
candidate region identified an open reading frame coding
for a protein of 435 amino acids (47,435 D) that shared
∼88% homology with rat Cx46. Mutation analysis of
GJA3 in two families with CZP3 detected distinct se-
quence changes that were not present in a panel of 105
normal, unrelated individuals. In family B, an ArG tran-
sition resulted in an asparagine-to-serine substitution at
codon 63 (N63S) and introduced a novel MwoI restric-
tion site. In family E, insertion of a C at nucleotide 1137
(1137insC) introduced a novel BstXI site, causing a
frameshift at codon 380. Restriction analysis confirmed
that the novel MwoI and BstXI sites cosegregated with
the disease in families B and E, respectively. This study
identifies GJA3 as the sixth member of the connexin gene
family to be implicated in human disease, and it high-
lights the physiological importance of gap-junction com-
munication in the development of a transparent eye lens.
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Introduction
Congenital or infantile cataract is a sight-threatening
lens defect that presents with an estimated prevalence of
1–6 cases per 10,000 live births (Lambert and Drack
1996). Approximately 25% of all cases are inherited,
most often in a nonsyndromic autosomal dominant fash-
ion, with considerable inter- and intrafamilial clinical
variation (Merin 1991; Phelps Brown and Bron 1996).
At least 10 independent loci for autosomal dominant
congenital cataract (adCC) have been linked to seven
human chromosomes (reviewed by Hejtmancik 1998).
Mutations in genes for lens crystallins have been iden-
tified at adCC loci on 2q (Brackenhoff et al. 1994; Ste-
phan et al. 1999), 17q11–q12 (Kannabiran et al. 1998),
21q (Litt et al. 1997), and 22q (Litt et al. 1998). How-
ever, no obvious candidate genes exist at those loci on
1p (Eiberg et al. 1995; Ionides et al. 1997), 16q (Eiberg
et al. 1988), 17p (Berry et al. 1996), and 17q24 (Ar-
mitage et al. 1995).
Recently, a mutation in the gene for gap-junction pro-
tein a8 (GJA8), or connexin50 (Cx50), has been linked
with a zonular pulverulent form of adCC (CZP1; MIM
116200) on 1q (Shiels et al. 1998). Zonular pulverulent
cataract is characterized by numerous powdery or punc-
tate opacities located in different developmental regions
of the lens, and a second locus for this phenotype (CZP3;
MIM 601885) has been linked to chromosome 13q
(Mackay et al. 1997). The gene for gap-junction protein
a-3 (GJA3), or connexin46 (Cx46), has been localized
to chromosome 13q11–q12 (Mignon et al. 1996) and
is predominantly expressed in the lens (Paul et al. 1991).
The chromosomal location and lens-preferred expres-
sion of GJA3 suggested that it was a strong candidate
gene for CZP3. To gain further insight into the role of
connexin genes in hereditary cataract, we have isolated
GJA3 and performed mutation analysis in two families
of British descent segregating punctate opacities that
map to the CZP3 locus on 13q.
Subjects and Methods
Patients and Diagnosis
The family with cataract (family E) was ascertained
at Moorfields Eye Hospital, London, and, for this study,
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Figure 1 Slit-lamp photograph showing “punctate” opacities located throughout the lens of individual III:2 in family E (fig. 2)
10 affected and 5 unaffected members underwent a full
ophthalmic examination by one of us (A.I.). The opac-
ities (fig. 1) appeared coarse and granular toward the
central zone (fetal nucleus) of the lens, whereas fine dust-
like opacities predominated in the peripheral zone (ju-
venile cortex) of the lens. Hospital records confirmed
that bilateral cataract was usually present at birth or
developed during infancy, and there was no family his-
tory of other ocular or systemic abnormalities. Auto-
somal dominant inheritance of the cataract was sup-
ported by the presence of affected individuals in each of
the three generations, equal numbers of affected males
and females, and male-to-male transmission (fig. 2).
Genotyping and Linkage Analysis
Blood samples were taken from patients after in-
formed consent and with local approval from the ethics
committee. Genomic DNA preparation, PCR-based ge-
notyping using Ge´ne´thon microsatellite markers (Dib et
al. 1996), and linkage analysis with the LINKAGE pack-
age of programs (Lathrop et al. 1984; Atwood and Bry-
ant 1988) were performed essentially as described else-
where (Mackay et al. 1997).
Cloning and Sequencing
Primer pairs were designed from the rat Cx46 cDNA
sequence (GenBank accession number X57970) with
PrimerSelect (DNASTAR) and were used to amplify hu-
man and rodent genomic DNA under standard PCR con-
ditions. Sequence homology of resultant PCR products
was confirmed by use of BLAST in the GenBank data-
base. A reproducible 214-bp PCR fragment was used to
probe conventional Southern blots containing HindIII
digests of a set of 57 P1 artificial chromosomes (PACs)
that partially covered the candidate region for both
CZP3 and the skin disorder, hidrotic ectodermal dys-
plasia (HED; Kibar et al. 1996). An arrayed (12 # 8-
well) plasmid library of the positive PAC clone (1 mg)
was constructed in pUC18 HindIII/BAP (Pharmacia Bio-
tech) by standard techniques. The library was trans-
ferred to Hybond-N nylon membrane (Amersham) by
means of a 96-pin replicating tool and was hybridized
against the 214-bp probe. Positive plasmid clones were
sequenced manually by the dideoxy-chain–termination
method by means of a Sequenase Kit (US Biochemical)
or with an automated Li-Cor DNA sequencer 4200.
DNA sequence assembly was performed by SeqMan
(DNASTAR).
Mutation Screening
The entire coding region of the Cx46 gene (exon 2)
was amplified from affected individuals by use of gene-
specific primers for codons 1–7 and 430–stop (table 1)
under standard PCR conditions. The heterozygous PCR
product (∼1.3 kb) was either directly sequenced or sub-
cloned into the pGEM-T Easy vector (Promega) prior
to sequencing of the mutant and wild-type alleles by use
of internal gene-specific primers (table 1) and the ABI
Prism DyeDeoxy-terminator cycle sequencing kit (PE
Figure 2 Pedigree and haplotype analysis of family E showing segregation of eight microsatellite markers on chromosome 13, listed in descending order from the centromeric end. Squares and
circles symbolize males and females, respectively. Unblackened and blackened symbols denote unaffected and affected individuals, respectively. The proband is indicated with an arrow.
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Table 1
PCR Primers Used for Mutation Screening of the Human Cx46
Coding Region
Codon Strand Sequence
1–7 Sense 5′-ATGGGCGACTGGAGCTTTCT
29–36 Sense 5′-CTGTTCCTGTTCCGCATTTTGGT
96–103 Antisense 5′-TCCATGCGCACGATGTGCAGCA
123–129 Antisense 5′-TTGTCCTGCGGTGGCTCCTT
143–150 Sense 5′-CGCGCTGCTGCGGACCTACG
185–192 Sense 5′-CCTGCCCCAACACGGTGGACTG
207–214 Antisense 5′-TGACGCACAGGCCACAGCCAACAT
223–229 Antisense 5′-CTTCTTCCAGCCCAGGTGGTA
229–235 Sense 5′-AAGCTCAAGCAGGGCGTGAC
316–323 Sense 5′-AACGGCCACCACCACCTGCTGAT
329–335 Antisense 5′-GCTCGGCCGCCTGGTTGG
430–stop Antisense 5′-CTAGATGGCCAAGTCCTCCGG
Applied Biosystems). In family E, the same ∼1.3-kb frag-
ment was used to test for the novel BstXI site in affected
individuals. In family B, primers for codons 29–36 and
96–103 (table 1) were used to amplify the novel MwoI
site in affected individuals and to exclude 30 otherMwoI
sites within the coding exon of wild-type GJA3. Enzyme
digests were performed according to the manufacturer’s
instructions (New England Biolabs), and the resulting
restriction fragments were separated in agarose gels
stained with ethidium bromide.
Results
CZP3 Linkage and Refinement
Eighteen members of family E, including 10 affected
individuals, 5 unaffected individuals, and 3 spouses (fig.
2), were genotyped with Ge´ne´thon (AC)n microsatellite
markers (Dib et al. 1996) that spanned the CZP1 and
CZP3 loci. After exclusion of the CZP1 locus, we ob-
tained a maximum two-point LOD score (Zmax) of 3.91,
with no recombination ( ), at marker D13S175.v  0max
Multipoint analysis yielded ( ) atZ  3.92 v  0max max
both D13S1316 and D13S175 (data not shown).
Haplotype analysis (fig. 2) detected four affected in-
dividuals (II:4, III:4, III:5, and III:7) and one unaffected
female (II:7) who were obligate recombinants at the most
distal marker D13S217 in the region. No recombinant
individuals were observed between the cataract locus
and D13S1316, which is the most proximal marker on
13q, suggesting that the cataract locus lies in the genetic
interval D13S217–(19.1 cM)–D13S1316–cen–13pter.
This interval contains that defined elsewhere by the orig-
inal, unrelated CZP3 family (B), that is, D13S1243–
(11.5 cM)–D13S1316–cen–13pter (Mackay et al. 1997).
In agreement with recent genetic mapping data (Kibar
et al. 1996; Taylor et al. 1998), however, we have placed
D13S1236 distal rather than proximal to D13S175 (fig.
2) and have identified an individual (IV:8) in family B
(Mackay et al. 1997) who carried the disease haplotype
at D13S1316 and D13S175 but not at D13S1236. This
individual was previously designated as unaffected; how-
ever, our mutation data (fig. 4) suggested that he rep-
resented a case of reduced penetrance and was in fact
recombinant for the disease at D13S1236. Thus, the
combined Z values (table 2) and haplotytpe data from
families B and E gave a Zmax of 17.0 ( ) atv  0max
D13S175, and they indicated that the CZP3 locus lies
in the refined genetic interval D13S1236–D13S175–
D13S1316–cen–13pter.
GJA3 Isolation and Sequencing
To isolate the human gene GJA3 for mutation screen-
ing, we designed consensus PCR primers based on co-
dons 29–36 and 223–229 of the rat cDNA sequence for
Cx46 (GenBank accession number X57970). Sequence
alignment of the resulting 603-bp fragment amplified
from human genomic DNA in the GenBank database by
means of the BLAST algorithim (Altschul et al. 1990)
confirmed maximum homology with Cx46 homologues
rather than other connexins. We extended this sequence
to 687 bp by using a primer to codons 1–7 of human
Cx50 (GenBank accession number U34802), and we
identified the 5′ coding sequence for Cx46 (fig. 3). Si-
multaneously, a 214-bp PCR fragment was amplified
from a chromosome 13–only somatic cell hybrid by use
of consensus primers to codons 143–150 and 207–214
of rat Cx46. Southern blot analysis showed that this
Cx46 PCR product hybridized with a 4.7-kb HindIII
restriction fragment (data not shown) derived from a
PAC clone that mapped to the candidate region for both
CZP3 and HED on 13q (Kibar et al. 1996). Sequencing
of this P1 fragment detected a single open reading frame
coding for a protein of 435 amino acids with a calculated
molecular mass of 47,435 D (fig. 3). Overall, the human
Cx46 sequence (GenBank accession number GJA3,
AFO75290) shared ∼88% homology and ∼70% identity
with that of the rat, particularly in the transmembrane
and extracellular domains of the protein.
GJA3 Mutation Analysis
Mutation analysis of the Cx46 gene in the families
with cataracts detected two significant changes from
wild type (fig. 3). In family B, an adenine to guanine
transition at nucleotide 188 of the coding region
(188ArG) resulted in the introduction of a novel MwoI
restriction enzyme site that cosegregated with the disease
(fig. 4). In family E, insertion of a cytosine after coding
nucleotide 1137 (1137insC) introduced a novel BstXI
restriction site that also cosegregated with the disease
phenotype (fig. 5). Neither of these sequence changes
was detected in a panel of 105 unrelated, normal indi-
viduals (data not shown), implying that 188ArG and
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Figure 3 Nucleotide and deduced amino acid sequence of human
Cx46. The four putative transmembrane regions are underlined.
Amino acids 42–74 and 174–200 are believed to form the extracellular
loops (E1 and E2), and the remainder of the protein is cytoplasmic.
The N63S missense mutation (family B) lies in the first extracellular
loop (E1), and the 1137insC mutation (family E) causes a frameshift
at amino acid 380 in the cytoplasmic carboxy-terminus. In-frame
translation stop codons are indicated by asterisks.
Table 2
Combined Two-Point Z Values for Linkage between CZP3 in Families B and E and
Chromosome 13 Markers
MARKER
Z AT v 
Zmax vmax.00 .01 .05 .10 .20 .30 .40
13pter-cen
D13S1316 5.76 5.64 5.16 4.53 3.21 1.83 .64 5.76 .00
D13S175 7.44 7.31 6.78 6.08 4.55 2.86 1.18 7.44 .00
D13S1236  4.57 4.82 4.56 3.65 2.48 1.13 4.82 .05
D13S1275  4.88 5.13 4.83 3.85 2.64 1.34 5.13 .05
D13S292 4.86 4.83 4.64 4.29 3.42 2.36 1.19 4.86 .00
D13S1243  3.09 3.88 3.88 3.24 2.24 1.06 3.89 .08
D13S283  5.19 5.99 5.82 4.74 3.20 1.42 5.99 .05
D13S217  6.74 2.20 .54 .60 .77 .49 .77 .30
1137insC are allelic cataract mutations rather than rare
polymorphisms.
Discussion
The connexin gene family encodes gap-junction chan-
nel proteins that mediate the intercellular transport of
small biomolecules (!1 kD) including ions, metabolites,
and second messengers in diverse vertebrate cell types,
including cochlea cells (Kelsell et al. 1997), Schwann
cells (Bergoffen et al. 1993), epidermal cells (Richard et
al. 1998), and lens fiber cells (White et al. 1994). At
least 10 genes for connexins of varying molecular mass
(∼26–50 kD) have been identified in humans (GenBank).
Mutations in the genes for Cx26 (GJB2), Cx31 (GJB3),
Cx32 (GJB1), Cx43 (GJA1), and Cx50 (GJA8) have
been associated with certain types of deafness (Kelsell
et al. 1997; Xia et al. 1998), skin disease (Richard et al.
1998), peripheral neuropathy (Bergoffen et al. 1993),
heart defects (Britz-Cunningham et al. 1995), and cat-
aracts (Shiels et al. 1998), respectively. In the present
study, we have refined the locus for zonular pulverulent
cataract (CZP3) to the genetic interval D13S1236–
cen–13pter and have identified distinct mutations in
GJA3, the gene for Cx46. Our data provide a genetic
map location for GJA3 and constitute the first report
implicating Cx46 in human inherited cataract.
The 188ArG missense mutation is likely to result in
an asparagine-to-serine substitution at codon 63 (N63S)
of Cx46. This represents a relatively conservative amino
acid change, as both asparagine (amide side group) and
serine (hydroxyl side group) are neutral under physio-
logic conditions. Asparagine, however, is strictly con-
served at codon 61, 62, or 63 within the first extracel-
lular loop (E1) of all vertebrate connexins (GenBank).
The extracellular domains of connexins are believed to
mediate the intercellular docking of connexon hemi-
channels (i.e., connexin hexamers) and enable the for-
mation of gap-junction channels composed of connexin
dodecamers (reviewed by Simon and Goodenough
1998). Thus, the N63S substitution may induce a defect
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Figure 4 Mutation analysis of the Cx46 gene in family B. a,
Heterozygote sequence (sense strand) showing an ArG transition (ar-
row) in codon 63 that changed asparagine (AAC) to serine (AGC) and
introduced an MwoI site (GCN5N2GC). b, Restriction fragment length
analysis showing that gain of the novel MwoI site cosegregated with
affected individuals (blackened symbols) heterozygous for the ArG
transition (225, 124, and 101 bp) but not with unaffected individuals
and spouses (225 bp only). Figure 5 Mutation analysis of the Cx46 gene in family E. A,
Wild-type allele (antisense strand) showing translation of an in-frame
glycine and serine at codons 379 (5′-GGC) and 380 (5′-AGC), re-
spectively. B, Mutant allele (antisense strand) showing that insertion
of a G (arrow) after coding nucleotide 1137 (i.e., 1137insC on the
sense strand) introduced a BstXI site (CCAN5NTGG). C, Restriction
fragment–length analysis showing that gain of the novel BstXI site
cosegregated with affected individuals (blackened symbols) hetero-
zygous for the 1137insC mutation (625, 460, and 165 bp) but not
with unaffected individuals and spouses (625 bp only).
in the E1 secondary structure that impairs Cx46-medi-
ated coupling of lens fiber cells. Similarly, a D47A mis-
sense mutation in the E1 domain of Cx50 has been as-
sociated with dominant congenital cataract in the No2
mouse (Steele et al. 1998). Furthermore, mutations in
the extracellular domains of human Cx26 (Denoyelle et
al. 1998) and Cx31 (Xia et al. 1998) have been impli-
cated in dominant forms of neurosensory deafness,
whereas similar mutations in Cx32 are associated with
an X-linked form of Charcot-Marie-Tooth neuropathy
(Krawczak and Cooper 1997).
The 1137insC mutation is predicted to cause a frame-
shift immediately after codon 379 of the Cx46 gene.
This results in the mistranslation of the final 56 amino
acids of the wild-type protein and the addition of 31
amino acids to the carboxy terminus of the mutant pro-
tein before an in-frame translation stop codon is detected
(fig. 3). Alignment of the 87 novel amino acids in the
SWISS-PROT database failed to detect significant ho-
mology with other known proteins. An inherited frame-
shift mutation in the carboxy-terminal domain of Cx26
has been associated with a recessive form of neurosen-
sory deafness (Kelley et al. 1998). However, unlike the
1137insC frameshift mutation in Cx46, this mutation
in Cx26 results from a 2-bp deletion that introduces a
premature translation stop codon. Notably, the
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1137insC mutation abolished potential phosphorylation
sites at the cytoplasmic carboxyl end of Cx46. Recessive
mutations at similar sites in Cx43 have been associated
with visceroatrial heterotaxia syndrome (Britz-Cunning-
ham et al. 1995), although these findings are contro-
versial (Toth et al. 1998).
We have demonstrated that dominant mutations in
the genes for Cx46 (present study) and Cx50 (Shiels et
al. 1998) are associated with “punctate” cataracts in
humans. Both of these connexins have been shown to
colocalize in gap junctions that permeate the lens (Jiang
and Goodenough 1996). Such heteromeric channels are
believed to facilitate the continuous flow of ions, me-
tabolites, and other small biomolecules (!1 kD) neces-
sary for maintaining lens clarity. Functional expression
studies of a dominant deafness mutation in Cx26 (White
et al. 1998a) suggest that the Cx46 and Cx50 mutants
described here and elsewhere (Shiels et al. 1998; Steele
et al. 1998) may exert dominant inhibitory effects on
their wild-type counterparts in vivo. The recent dem-
onstrations that mice deficient in either Cx46 (Gong et
al. 1997) or Cx50 (White et al. 1998b) also develop
cataracts confirm the vital role of these connexins in lens
physiology and provide model systems for elucidating
the pathogenetic mechanisms associated with Cx46 and
Cx50 defects in humans.
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